Inclusion body myopathy 2

Active Research Protocols

  1. 05-HG-0236 – Pilot Study of the Use of Intravenous Immune Globulin in Hereditary Inclusion Body Myopathy
  2. 11-HG-0218 – A Natural History Study of Patients with Hereditary Inclusion Body Myopathy (HIBM)
  3. 12-HG-0207 – A Phase 1 Randomized, Placebo-Controlled, Double-Blind, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects with GNE myopathy or Hereditary Inclusion Body Myopathy (HIBM)
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014